GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.Erasca Stock Plunges 48% on Patent Dispute; Law Firm Launches Shareholder Investigation
Erasca faces shareholder lawsuit investigation after patent infringement claim from Revolution Medicines over ERAS-0015 candidate triggers dramatic 48% stock collapse.
RVMDRVMDWERASstock price declinesecurities litigation